Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Iacs-13909
2. 2160546-07-4
3. 1-[3-(2,3-dichlorophenyl)-2h-pyrazolo[3,4-b]pyrazin-6-yl]-4-methylpiperidin-4-amine
4. 1-(3-(2,3-dichlorophenyl)-1h-pyrazolo[3,4-b]pyrazin-6-yl)-4-methylpiperidin-4-amine
5. 1-(3-(2,3-dichlorophenyl)-2h-pyrazolo[3,4-b]pyrazin-6-yl)-4-methylpiperidin-4-amine
6. Schembl19641152
7. Bbp 398
8. Bbp-398
9. Us10280171, Example 1
10. Bdbm384117
11. Glxc-26922
12. Ex-a4355
13. S9703
14. Akos040759720
15. Ac-36570
16. Ms-26129
17. Hy-137092
18. Cs-0136474
19. F82752
20. U9y
| Molecular Weight | 377.3 g/mol |
|---|---|
| Molecular Formula | C17H18Cl2N6 |
| XLogP3 | 3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 2 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 83.7 |
| Heavy Atom Count | 25 |
| Formal Charge | 0 |
| Complexity | 472 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
14
PharmaCompass offers a list of BBP-398 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right BBP-398 manufacturer or BBP-398 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred BBP-398 manufacturer or BBP-398 supplier.
A HY-137092 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of HY-137092, including repackagers and relabelers. The FDA regulates HY-137092 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. HY-137092 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A HY-137092 supplier is an individual or a company that provides HY-137092 active pharmaceutical ingredient (API) or HY-137092 finished formulations upon request. The HY-137092 suppliers may include HY-137092 API manufacturers, exporters, distributors and traders.
HY-137092 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of HY-137092 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right HY-137092 GMP manufacturer or HY-137092 GMP API supplier for your needs.
A HY-137092 CoA (Certificate of Analysis) is a formal document that attests to HY-137092's compliance with HY-137092 specifications and serves as a tool for batch-level quality control.
HY-137092 CoA mostly includes findings from lab analyses of a specific batch. For each HY-137092 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
HY-137092 may be tested according to a variety of international standards, such as European Pharmacopoeia (HY-137092 EP), HY-137092 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (HY-137092 USP).
